参考文献 References
[1] HERRSTEDT J,ROILA F,WARR D, et al. 2016 Updated MASCC/ ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy[J]. Supportive Care in Cancer, 2017, 25(1):277-288.
[2] 郭芷君,徐峰.化学治疗所致恶心呕吐分类与药物治疗的研究进展[J].中国药业,2020,29(22):1-6.
[3] 王涵,王洪学,谢伟敏,等.重复使用 5-HT3受体拮抗剂预防多日化疗相关性恶心呕吐的疗效和安全性分析[J].中国肿瘤临床,2017(13):125-126.
[4] 聂微,严芝强,成兴真,等.奥沙利铂通过自噬诱导胃癌细胞耐药的机制[J].实用医学杂志,2022,38(7):828-35.
[5] 张顺同. 帕洛诺司琼胶囊、注射液及托烷司琼注射液预防HEC、MEC所致CINV的成本效果分析[D]. 河南:郑州大学,2017.
[6] Ajani JA, D'Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw. 2022;20(2): 167-192.
[7] Mosa ASM, Hossain AM, Yoo I. A dynamic prediction engine to prevent chemotherapy-induced nausea and vomiting[J]. Artif Intell Med. 2020;109:101925.
[8] 中国抗癌协会肿瘤临床化疗专业委员会,中国抗癌协会肿瘤支持治疗专业委员会.中国肿瘤药物治疗相关恶心呕吐防治专家共识(2022年版)[J].中华医学杂志,2022,102(39):3080-3094.
[9] Kuchuk I, Bouganim N, Beusterien K, et al. Preference weights for chemotherapy sideeffects from the perspective of women with breast cancer[J]. Breast Cancer ResTreat,2013,142(1):101-7.
[10] Brenner H, Rothenbacher D, Arndt V, et al. Epidemiology of stomach cancer[J]. Methods Mol Biol, 2009, 472 (5450):1567-1568.
[11] Harada K,Yamashita K,Iwatsuki M,et al.Intraperitoneal therapy for gastric cancer peritoneal carcinomatosis[J]. Expert Rev Clin Pharmacol.2022;15(1):43-49.
[12] Park JK,Seo JS,Lee SKet alCombinatorial antitumor activity of oxaliplatin with epigenetic modifying agents, 5-Aza-CdR and FK228,in human gastric cancer cells[J]. Biomol Ther,2018,26 (6) : 591-598
[13] Cheng Y, Wu Z, Shi L, et al. Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial[J]. EClinicalMedicine. 2022;49: 101480.
[14] Lorusso V,Spedicato A,Petrucelli L,et al.Single dose of palonoseLron plus dexamethasone to control nausea, vomiting and to warrant an adequate food intake in patients created with highly eme-togenic chemotherapy ( HEC)[J].Support CareCancer.2009,17( 12):1469-1473
[15] Aogi K, Takeuchi H, Saeki T, et al. Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis[J]. Int J Clin Oncol. 2021;26(1):1-17.
[16] Cho E, Kim DH, Shin S, et al. Efficacy of Palonosetron- Dexamethasone Combination Versus Palonosetron Alone for Preventing Nausea and Vomiting Related to Opioid-Based Analgesia: A Prospective, Randomized, Double-blind Trial[J]. Int J Med Sci. 2018;15(10): 961-968.